Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report)’s share price rose 13.7% during trading on Tuesday . The company traded as high as $0.6892 and last traded at $0.6510. Approximately 950,712 shares were traded during trading, an increase of 4,102% from the average daily volume of 22,626 shares. The stock had previously closed at $0.5728.
Bellevue Life Sciences Acquisition Stock Down 5.6%
The firm’s fifty day moving average is $0.63 and its two-hundred day moving average is $0.81.
About Bellevue Life Sciences Acquisition
Bellevue Life Sciences Acquisition Corp. (NASDAQ: BLAC) is a special purpose acquisition company organized as a Delaware corporation. The company completed its initial public offering in 2021, raising gross proceeds to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more life sciences businesses.
BLAC’s principal activity is to identify and complete a business combination with a target operating company in the life sciences sector.
See Also
- Five stocks we like better than Bellevue Life Sciences Acquisition
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Do you know what Amazon is planning for January 1?
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
